An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
Profound progress has been made in cancer treatment in the past three decades. However, drug resistance remains prevalent and a critical challenge. Drug resistance can be attributed to oncogenes mutations, activated defensive mechanisms, ATP-bind cassette transporters overexpression, cancer stem cel...
| 發表在: | Frontiers in Pharmacology |
|---|---|
| Main Authors: | Qingmei Ye, Xin Zhou, Han Ren, Fangxuan Han, Rong Lin, Juan Li |
| 格式: | Article |
| 語言: | 英语 |
| 出版: |
Frontiers Media S.A.
2023-10-01
|
| 主題: | |
| 在線閱讀: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1274336/full |
相似書籍
Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis
由: Donghao Tang, et al.
出版: (2024-01-01)
由: Donghao Tang, et al.
出版: (2024-01-01)
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
由: Jiani Yuan, et al.
出版: (2017-11-01)
由: Jiani Yuan, et al.
出版: (2017-11-01)
Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
由: Die Zhang, et al.
出版: (2023-03-01)
由: Die Zhang, et al.
出版: (2023-03-01)
Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
由: Jiani Yuan, et al.
出版: (2019-07-01)
由: Jiani Yuan, et al.
出版: (2019-07-01)
Rod-shaped mesoporous silica nanoparticles reduce bufalin cardiotoxicity and inhibit colon cancer by blocking lipophagy
由: Yibao Fan, et al.
出版: (2024-09-01)
由: Yibao Fan, et al.
出版: (2024-09-01)
Bufalin-Mediated Regulation of Cell Signaling Pathways in Different Cancers: Spotlight on JAK/STAT, Wnt/β-Catenin, mTOR, TRAIL/TRAIL-R, and Non-Coding RNAs
由: Ammad Ahmad Farooqi, et al.
出版: (2023-02-01)
由: Ammad Ahmad Farooqi, et al.
出版: (2023-02-01)
Effect of Bufalin on Proliferation and Apoptosis of Human Non-small Cell Lung Cancer A549 Cell
由: Zhitu ZHU, et al.
出版: (2010-09-01)
由: Zhitu ZHU, et al.
出版: (2010-09-01)
Bufalin targets the SRC-3/c-Myc pathway in chemoresistant cells to regulate metastasis induced by chemoresistance in colorectal cancer
由: Jinbao Chen, et al.
出版: (2025-02-01)
由: Jinbao Chen, et al.
出版: (2025-02-01)
Bufalin Inhibits Cellular Proliferation and Cancer Stem Cell-Like Phenotypes via Upregulation of MiR-203 in Glioma
由: Tao Liu, et al.
出版: (2017-11-01)
由: Tao Liu, et al.
出版: (2017-11-01)
Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma
由: Zhouyu Ning, et al.
出版: (2022-06-01)
由: Zhouyu Ning, et al.
出版: (2022-06-01)
Traditional Chinese medicine bufalin inhibits infectious hematopoietic necrosis virus infection in vitro and in vivo
由: Jing-Zhuang Zhao, et al.
出版: (2024-03-01)
由: Jing-Zhuang Zhao, et al.
出版: (2024-03-01)
Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation
由: Jingwen Liu, et al.
出版: (2025-08-01)
由: Jingwen Liu, et al.
出版: (2025-08-01)
Simultaneous induction of immunogenic cell death and PD-L1 downregulation by bufalin-based nanovaccines for potentiate HCC immunotherapy
由: Zhe Li, et al.
出版: (2025-12-01)
由: Zhe Li, et al.
出版: (2025-12-01)
Bufalin-loaded vitamin E succinate-grafted chitosan oligosaccharide/RGD-conjugated TPGS mixed micelles inhibit intraperitoneal metastasis of ovarian cancer
由: Lan Xu, et al.
出版: (2023-03-01)
由: Lan Xu, et al.
出版: (2023-03-01)
Multi-b-value DWI to evaluate the synergistic antiproliferation and anti-heterogeneity effects of bufalin plus sorafenib in an orthotopic HCC model
由: Ran Guo, et al.
出版: (2024-03-01)
由: Ran Guo, et al.
出版: (2024-03-01)
Bufalin targeting CAMKK2 inhibits the occurrence and development of intrahepatic cholangiocarcinoma through Wnt/β-catenin signal pathway
由: Huhu Zhang, et al.
出版: (2023-12-01)
由: Huhu Zhang, et al.
出版: (2023-12-01)
Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds Bufalin and Lycorine
由: Julia Mester-Tonczar, et al.
出版: (2020-08-01)
由: Julia Mester-Tonczar, et al.
出版: (2020-08-01)
ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
由: Laura Soumoy, et al.
出版: (2024-01-01)
由: Laura Soumoy, et al.
出版: (2024-01-01)
Bufalin-Loaded Multifunctional Photothermal Nanoparticles Inhibit the Anaerobic Glycolysis by Targeting SRC-3/HIF-1α Pathway for Improved Mild Photothermal Therapy in CRC
由: Shang J, et al.
出版: (2024-08-01)
由: Shang J, et al.
出版: (2024-08-01)
Bufalin Suppresses Esophageal Squamous Cell Carcinoma Progression through Protein Arginine Methyltransferase-6/AKT/Mammalian Target of Rapamycin Pathway Inhibition
由: Yao-Ke Jia, et al.
出版: (2025-01-01)
由: Yao-Ke Jia, et al.
出版: (2025-01-01)
Toad venom-derived bufadienolides and their therapeutic application in prostate cancers: Current status and future directions
由: Qingmei Ye, et al.
出版: (2023-03-01)
由: Qingmei Ye, et al.
出版: (2023-03-01)
Targeting the inhibitors of apoptosis proteins (IAPs) to combat drug resistance in cancers
由: Qingmei Ye, et al.
出版: (2025-03-01)
由: Qingmei Ye, et al.
出版: (2025-03-01)
Bufalin Suppresses Colorectal Cancer Liver Metastasis by Inhibiting De Novo Fatty Acid Synthesis via the PI3K/AKT-Mediated SREBP1/FASN Pathway
由: Wenwen Pang, et al.
出版: (2025-09-01)
由: Wenwen Pang, et al.
出版: (2025-09-01)
Isoflurane treatment for refractory and super-refractory status epilepticus in dogs
由: Eirini Sarpekidou, et al.
出版: (2024-03-01)
由: Eirini Sarpekidou, et al.
出版: (2024-03-01)
Uncovering the Mechanisms of Active Components from Toad Venom against Hepatocellular Carcinoma Using Untargeted Metabolomics
由: Pan Liang, et al.
出版: (2022-11-01)
由: Pan Liang, et al.
出版: (2022-11-01)
Government Strategy for Overcoming Poverty in Cilegon City, Indonesia
由: Leni Cahyani, et al.
出版: (2024-09-01)
由: Leni Cahyani, et al.
出版: (2024-09-01)
UBA3 promotes the occurrence and metastasis of intrahepatic cholangiocarcinoma through MAPK signaling pathway
由: Zhang Huhu, et al.
出版: (2024-01-01)
由: Zhang Huhu, et al.
出版: (2024-01-01)
Influence of Different Ratios of DSPE-PEG2k on Ester Prodrug Self-Assembly Nanoparticles for Cell Migration and Proliferation Suppression
由: Zhang H, et al.
出版: (2024-03-01)
由: Zhang H, et al.
出版: (2024-03-01)
Comparative Pharmacokinetics of Cinobufacini Capsule and Injection by UPLC-MS/MS
由: Ming Li, et al.
出版: (2022-07-01)
由: Ming Li, et al.
出版: (2022-07-01)
The Role of Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Past, Present, and Future Directions
由: Matteo Piccini, et al.
出版: (2023-05-01)
由: Matteo Piccini, et al.
出版: (2023-05-01)
Current status and future prospects of clinical trials for radioiodine-refractory thyroid cancer
由: LI Ruping, YANG Hui
出版: (2025-01-01)
由: LI Ruping, YANG Hui
出版: (2025-01-01)
Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
由: William G. Ambler, et al.
出版: (2022-12-01)
由: William G. Ambler, et al.
出版: (2022-12-01)
Environmental performance of refractories: A state-of-the-art review on current methodological practices and future directions
由: Sarah Badioli, et al.
出版: (2025-09-01)
由: Sarah Badioli, et al.
出版: (2025-09-01)
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
由: Emmanuel Gyan, et al.
出版: (2015-02-01)
由: Emmanuel Gyan, et al.
出版: (2015-02-01)
Aborted and Refractory Status Epilepticus Compared
由: J Gordon Millichap
出版: (2008-05-01)
由: J Gordon Millichap
出版: (2008-05-01)
Management of the refractory vitiligo patient: current therapeutic strategies and future options
由: Xinju Wang, et al.
出版: (2024-01-01)
由: Xinju Wang, et al.
出版: (2024-01-01)
Refractory status epilepticus
由: Sanjay P Singh, et al.
出版: (2014-01-01)
由: Sanjay P Singh, et al.
出版: (2014-01-01)
Outcome of Refractory Status Epilepticus
由: J Gordon Millichap
出版: (2002-01-01)
由: J Gordon Millichap
出版: (2002-01-01)
Spinal Cord Stimulation for Refractory Angina Pectoris: Current Status and Future Perspectives, a Narrative Review
由: Roberto Gazzeri, et al.
出版: (2025-01-01)
由: Roberto Gazzeri, et al.
出版: (2025-01-01)
Cardiac Glycosides as Autophagy Modulators
由: Jan Škubník, et al.
出版: (2021-11-01)
由: Jan Škubník, et al.
出版: (2021-11-01)
相似書籍
-
Global trends in bufalin application research for cancer from 2003 to 2022: A bibliometric and visualised analysis
由: Donghao Tang, et al.
出版: (2024-01-01) -
Improved Antitumor Efficacy and Pharmacokinetics of Bufalin via PEGylated Liposomes
由: Jiani Yuan, et al.
出版: (2017-11-01) -
Bufalin reverses ABCB1-mediated resistance to docetaxel in breast cancer
由: Die Zhang, et al.
出版: (2023-03-01) -
Bufalin-Loaded PEGylated Liposomes: Antitumor Efficacy, Acute Toxicity, and Tissue Distribution
由: Jiani Yuan, et al.
出版: (2019-07-01) -
Rod-shaped mesoporous silica nanoparticles reduce bufalin cardiotoxicity and inhibit colon cancer by blocking lipophagy
由: Yibao Fan, et al.
出版: (2024-09-01)
